Paradigm Biopharmaceuticals Ltd.ASX: PAR

EAP treatment completed and Orphan Status achieved for MPS-I

Apr 30, 2020 at 4:45 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment